FDA gets tough on promotion
This article was originally published in Clinica
Executive Summary
The US FDA is clamping down on promotion of unapproved uses for devices. Among companies which have been issued warning letters for promotional activities are US Surgical (see Clinica No 710, p 8) and, more recently, OrthoLogic.